Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
doi: 10.1002/hep.20045 148
Potential benefits of this infusion include enhanced cellular support, promotion of healthy aging, and a radiant, revitalized look
Previous studies have demonstrated that APAP intoxication disrupts the temporal dynamics of hepatic lipid metabolism (Xiong et al
Ye, S., et al
1 Introduction Diabetic retinopathy (DR), a leading cause of vision impairment among working-age adults, affects approximately 146 million individuals globally, with projections estimating an increase to 180 million by 2030, driven by the rising prevalence of diabetes, particularly in low- and middle-income countries ( The pathophysiology of early DR involves a complex interplay of hyperglycemia-induced microvascular damage, inflammation, oxidative stress, and advanced glycation end product (AGE) accumulation ( Advances in diagnostic technologies, including ultra-widefield fundus photography, optical coherence tomography (OCT), OCT angiography (OCTA), and artificial intelligence (AI)-based algorithms, have revolutionized early NPDR detection, achieving over 95% accuracy and enabling prediction of systemic risks ( This review synthesizes the molecular basis of early-stage DR, compares its pathophysiology between T1DM and T2DM, evaluates diagnostic innovations, and explores therapeutic advancements supported by recent clinical trials and real-world data
Peer review Peer review information Nature Communications thanks Nicolas Rouhier and Mirko Zaffagnini for their contribution to the peer review of this work
US$ 26.04
US$ 29.90
US$ 23.13
